Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-17-016284)

Filing Details

Accession Number:: 0001225208-17-016284
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-10-16 17:26:00
Reporting Period:: 2016-12-20

Accepted Time:: 2017-10-16 17:26:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1611777	C James Smith	Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-12-20	1,566	$32.84	1,566	No	4	P	Indirect	By Spouse
Common Stock	Disposition	2016-12-28	24	$32.38	1,542	No	4	S	Indirect	By Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Spouse
No	4	S	Indirect	By Spouse

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,000	Direct

Footnotes

The reporting person disclaims beneficial ownership of the shares held in his spouse's IRA, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.